
|Articles|June 1, 1999
Supplements and Featured Publications
- Clinical and Economic Impact of Breast Cancer Treatment and Prevention in High-Risk Women
- Volume 5
- Issue 6 Suppl
Benefits Foregone: Too Much of the Wrong and Too Little of the Right
Author(s)Bernard S. Bloom, PhD
Advertisement
Articles in this issue
over 26 years ago
Participating Facultyover 26 years ago
Breast Cancer Epidemiology: An Overviewover 26 years ago
Overview of Cancer Economicsover 26 years ago
Breast Cancer Stage Cost Analysis in a Managed Care Populationover 26 years ago
Question-and-Answer Sessionover 26 years ago
Selected AbstractsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Chemoradiotherapy Improved Survival in Older Patients With Stage 2 NSCLC
2
Single-Tablet Bictegravir/Lenacapavir Effective After Treatment Switch
3
Non-Invasive Tests Show Promise for Tracking Treatment Response in Semaglutide MASH Trial
4
Flow Cytometry Tracks CAR T-Cell Therapy Persistence in Aggressive LBCL
5















































